Sufentanil Citrate (Akorn, Inc.)
Welcome to the PulseAid listing for the Sufentanil Citrate drug offered from Akorn, Inc.. This Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Sufentanil Citrate |
SUBSTANCE NAME: | SUFENTANIL CITRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
ROUTE: | EPIDURAL; INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-12-01 |
END MARKETING DATE: | 0000-00-00 |
Sufentanil Citrate HUMAN PRESCRIPTION DRUG Details:
Item Description | Sufentanil Citrate from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 50(ug/mL) |
START MARKETING DATE: | 2010-12-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-050_ada2f7c7-1ba9-4216-8496-5df11556392c |
PRODUCT NDC: | 17478-050 |
APPLICATION NUMBER: | NDA019050 |
Other SUFENTANIL CITRATE Pharmaceutical Manufacturers / Labelers: